U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07870031) titled 'Clinical Evaluation of TrHCROSS(R) for Different Joints' on Oct. 06.
Brief Summary: This post-market clinical investigation is designed to evaluate the safety and effectiveness of TrHCROSS(R), a CE-marked cross-linked hyaluronic acid viscosupplement, in patients with mild to moderate osteoarthritis of the knee, hip, or shoulder who have experienced an inadequate response to conservative treatments and standard analgesic therapy. The study is a prospective, randomized, single-blind, active-controlled, non-inferiority trial enrolling 150 participants, who will receive a single intra-articular injection of either TrHCROSS(R) or a refer...